Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873. Medicine and Society Jan 2010 Gender Diversity and Nurse-Physician Relationships Beth Ulrich, EdD, RN Gender and cross-professional perceptions affect nurse-physician relationships. Virtual Mentor. 2010;12(1):41-45. doi: 10.1001/virtualmentor.2010.12.1.msoc1-1001. Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3
Medicine and Society Oct 2019 Which Ethical Considerations Should Inform Hospice Decisions About Caring for Patients With Obesity? Chithra R. Perumalswami, MD, MSc, Brycin D. Hanslits, and Susan D. Goold, MD, MA, MHSA Current evidence suggests how hospice and palliative care clinicians can help advocate for high-quality, end-of-life care for patients with obesity. AMA J Ethics. 2019;21(10):E873-878. doi: 10.1001/amajethics.2019.873.
Medicine and Society Jan 2010 Gender Diversity and Nurse-Physician Relationships Beth Ulrich, EdD, RN Gender and cross-professional perceptions affect nurse-physician relationships. Virtual Mentor. 2010;12(1):41-45. doi: 10.1001/virtualmentor.2010.12.1.msoc1-1001.
Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494.